Discover 1,506 paid clinical trials in Loveland, Colorado. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,506
Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2
for
Neurotrophic Keratopathy
Location: Longmont CO, Chesterfield MO, St Louis MO,
Sponsor: ReGenTree, LLC
Sex: All
Age: 18+
Code: NCT05555589
Phase 3, Recruiting
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Longmont CO, Lakewood CO, Salt Lake City UT,
Sponsor: Apellis Pharmaceuticals, Inc.
Sex: All
Age: 60+
Code: NCT07215390
Phase 2, Recruiting
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
for
Inflammatory Breast Carcinoma, Invasive Breast Carcinoma,
Location: Greeley CO, Gilbert AZ, The Woodlands TX, Houston TX,
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT00477100
Recruiting
A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer
Location: Boulder CO, Santa Monica CA, San Jose CA,
Sponsor: Vanda Pharmaceuticals
Sex: All
Age: 2 - 65
Code: NCT05361707
Phase 3, Recruiting
Effectiveness of Combining Light and Non-Light Treatments for Jet Lag and Sleep Disorders
for
Sleep Disorders, Circadian Rhythm
Location: Boulder CO
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Sex: All
Age: 18 - 40
Code: NCT00387179
Recruiting
Biomarkers for Peripheral Circadian Clocks in Humans
for
Circadian Rhythms
Location: Boulder CO
Sponsor: University of Colorado, Boulder
Sex: All
Age: 17 - 35
Code: NCT06296823
Recruiting
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases